Efficacy of abrocitinib monotherapy for the treatment of moderate-to-severe atopic dermatitis by race

被引:0
作者
Alexis, A. F. [1 ]
Silverberg, J. I. [2 ]
Rice, Z. P. [3 ]
Armstrong, A. W. [4 ]
Desai, S. R. [5 ,6 ]
Fonacier, L. [7 ]
Kabashima, K. [8 ]
Levenberg, M. [9 ]
Biswas, P. [9 ]
Cella, R. Rojo [10 ]
Chan, G. L. [10 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[3] Dermatol Associates Georgia, Atlanta, GA USA
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[5] Innovat Dermatol, Plano, TX USA
[6] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[7] NYU Langone Hosp Long Isl, Mineola, NY USA
[8] Kyoto Univ, Kyoto, Japan
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
516
引用
收藏
页码:E137 / E138
页数:2
相关论文
共 50 条
[21]   Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial programme [J].
Eichenfield, L. F. ;
Flohr, C. ;
Bangert, C. ;
Irvine, A. D. ;
Weidinger, S. ;
Nesnas, J. ;
Koppensteiner, H. ;
Zhang, F. ;
Rojo, R. ;
Chan, G. .
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) :E142-E143
[22]   Efficacy of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis using treat-to-target goals [J].
De Bruin-Weller, M. ;
Weidinger, S. ;
Gooderham, M. ;
Pink, A. ;
Silverberg, J. ;
DiBonaventura, M. ;
Kerkmann, U. ;
Lazariciu, I. ;
Clibborn, C. .
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) :E171-E171
[23]   Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis [J].
Staumont-Salle, Delphine ;
Barbarot, Sebastien ;
Bouaziz, Jean David ;
Chan, Chan ;
Clibborn, Claire ;
Du-Thanh, Aurelie ;
Feeney, Claire ;
Lejeune, Alexandre ;
Misery, Laurent ;
Nosbaum, Audrey ;
Seneschal, Julien ;
Soria, Angele ;
Zhang, Fan .
JEADV CLINICAL PRACTICE, 2023, 2 (03) :518-530
[24]   Dupilumab in the treatment of moderate-to-severe atopic dermatitis [J].
Kraft, Magdalena ;
Worm, Margitta .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) :301-310
[25]   Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis [J].
Khattri, Saakshi ;
Brunner, Patrick M. ;
Garcet, Sandra ;
Finney, Robert ;
Cohen, Steven R. ;
Oliva, Margeaux ;
Dutt, Riana ;
Fuentes-Duculan, Judilyn ;
Zheng, Xiuzhong ;
Li, Xuan ;
Bonifacio, Kathleen M. ;
Kunjravia, Norma ;
Coats, Israel ;
Cueto, Inna ;
Gilleaudeau, Patricia ;
Sullivan-Whalen, Mary ;
Suarez-Farinas, Mayte ;
Krueger, James G. ;
Guttman-Yassky, Emma .
EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) :28-35
[26]   Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults [J].
Zheng, Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 :72-72
[27]   Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis [J].
Bridgeman, Sarah G. ;
Martino, Anna K. ;
Strowd, Lindsay C. .
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) :2153-2159
[28]   Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults [J].
Xu, Xinghua ;
Zheng, Yi ;
Zhang, Xin ;
He, Yanling ;
Li, Chengxin .
ONCOTARGET, 2017, 8 (65) :108480-108491
[29]   Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis [J].
Khattri, S. ;
Brunner, P. M. ;
Garcet, S. ;
Finney, R. ;
Cohen, S. R. ;
Oliva, M. ;
Dutt, R. ;
Fuentes-Duculan, J. ;
Zheng, X. ;
Li, X. ;
Bonifacio, K. M. ;
Kunjravia, N. ;
Coats, I. ;
Cueto, I. ;
Gilleaudeau, P. ;
Sullivan-Whalen, M. ;
Suarez-Farinas, M. ;
Krueger, J. G. ;
Guttman-Yassky, E. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) :S41-S41
[30]   Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis [J].
Diana Bernardo ;
Thomas Bieber ;
Tiago Torres .
American Journal of Clinical Dermatology, 2023, 24 :753-764